Human Herpesvirus Vaccines and Future Directions


  • V. C. Emery

    Corresponding author
    • Department of Infection, University College London, UK and Department of Microbial and Cellular Sciences, University of Surrey, Guildford, UK
    Search for more papers by this author

Corresponding author: Vincent C. Emery


Over the last few years there has been an impressive increase in the virological and immunological tools available to detect both human herpesvirus (HHV) and immune control of replication post-solid organ transplantation. This has allowed a greater appreciation of pathogenesis, studies to be designed to evaluate potential vaccines, new approaches adopted for antiviral deployment and the success of interventions to be judged. This chapter aims to summarize the state-of-the-art in vaccine development and look forward to the role that vaccines, immune monitoring, viral kinetics and new antiherpesvirus agents may play in the future management of HHV infections after transplantation.